In particular, epidermal growth factor receptor (EGFR) inhibitors and tyrosine kinase inhibitors (TKIs) have been reported to lower serum zinc levels, potentially contributing to dermatologic toxicities such as xerosis and pruritus (10, 11). Here, EGFR is linked to Pruritus.